Skip to menu Skip to content Skip to footer
Dr Matthew Roberts
Dr

Matthew Roberts

Email: 
Phone: 
+61 7 334 66047

Overview

Background

Matthew J. Roberts, BSc, MBBS, PhD, FRACS (Urol)

  • Consultant Urologist, Royal Brisbane and Women’s (RBWH), Surgical Treatment and Rehabilitation Service (STARS), Queensland Health
  • Clinician Research Fellow, Metro North Hospital and Health Service
  • Group Leader & Associate Professor, The University of Queensland Centre for Clinical Research

Matthew is a medical graduate of The University of Queensland and completed Urology specialty training in Queensland and New South Wales. He completed his PhD under the supervision of Professor “Frank” Gardiner investigating new biomarkers for the early detection and characterization of prostate cancer.

Matthew is a surgeon-scientist, working clinically as a urologist and robotic surgeon at RBWH & STARS with academic appointment as Clinician Research Fellow at Metro North Health (Qld) and Associate Professor at UQCCR. His clinical and research interests are in Urologic cancers (e.g. prostate cancer), focusing on novel imaging and biomarkers, clinical trials, urological infections and innovation in urology. He has authored over 140 peer reviewed manuscripts in international journals and presented research at more than 20 international urology and clinical cancer meetings. He is a member of the EAU Prostate Cancer Guidelines Committee, Prostate Cancer Outcomes Registry (PCOR)-Queensland Steering Committee, Editorial Board of the BJU International, as well as Co-Convenor of the ANZUP 2024 ASM.

Availability

Dr Matthew Roberts is:
Available for supervision

Qualifications

  • Bachelor of Biomedical Science, The University of Queensland
  • Bachelor of Medicine, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Urology

    All fields related to urology including urologic oncology, prostate cancer, kidney/renal cancer, bladder cancer and others. Urologic infections Quality-of-life and survivorship research Systematic review and meta-analysis.

Works

Search Professor Matthew Roberts’s works on UQ eSpace

253 works between 2000 and 2025

41 - 60 of 253 works

2024

Journal Article

Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories

Aziz, Moez Karim, Molony, Donald, Monlezun, Dominique, Holder, Travis, Brunckhorst, Oliver, Higgason, Noel, Roland, Jerry, Magill, Resa, Fatakdawala, Mariya, Iacobucci, Alexander, Mody-Bailey, Neal, Owen, Chris, Zarker, Andrew, Thames, Emma, Swaby, Justin, Xiao, Daniel, Choi, Lily, Desai, Shubh, Galan, Jacob, Deng, Brett, Hartshorne, Taylor, Nichols, Alexis, Zhang, Allan, Imber, Jared, Song, Jeffrey, Jones, William, Rivas, Alexis, Sanchez, Darren, Guhan, Maya ... Canfield, Steven (2024). Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories. European Urology, 87 (1), 15-26. doi: 10.1016/j.eururo.2024.08.031

Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories

2024

Journal Article

Guidelines for genetic testing in prostate cancer: a scoping review

Tuffaha, Haitham, Edmunds, Kim, Fairbairn, David, Roberts, Matthew J., Chambers, Suzanne, Smith, David P, Horvath, Lisa, Arora, Shiksha and Scuffham, Paul (2024). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases, 27 (4), 594-603. doi: 10.1038/s41391-023-00676-0

Guidelines for genetic testing in prostate cancer: a scoping review

2024

Journal Article

Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database

Emmett, Louise, Papa, Nathan, Counter, William, Calais, Jeremie, Barbato, Francesco, Burger, Irene, Eiber, Matthias, Roberts, Matthew J., Agrawal, Shikha, Franklin, Anthony, Xue, Alan, Rasiah, Krishan, John, Nikeith, Moon, Daniel, Frydenberg, Mark, Yaxley, John, Stricker, Phillip, Wong, Keith, Coughlin, Geoff, Gianduzzo, Troy, Kua, Boon, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Hsiao, Edward, Sutherland, Tom, Perry, Elisa, Fendler, Wolfgang P. and Hope, Thomas A. (2024). Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database. Journal of Nuclear Medicine, 65 (1), 94-99. doi: 10.2967/jnumed.123.266164

Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database

2024

Journal Article

Etiology and management of urethral calculi: a systematic review of contemporary series

Morton, Andrew, Tariq, Arsalan, Dunglison, Nigel, Esler, Rachel and Roberts, Matthew J. (2024). Etiology and management of urethral calculi: a systematic review of contemporary series. Asian Journal of Urology, 11 (1), 10-18. doi: 10.1016/j.ajur.2021.12.011

Etiology and management of urethral calculi: a systematic review of contemporary series

2024

Journal Article

Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?

Roberts, Matthew J., Cornford, Philip and Tilki, Derya (2024). Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?. European Urology, 87 (2), 261-263. doi: 10.1016/j.eururo.2024.12.001

Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?

2024

Journal Article

EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer

Tilki, Derya, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, J.L.H. van Leenders, Geert, Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Cornford, Philip (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer. European Urology, 86 (2), 164-182. doi: 10.1016/j.eururo.2024.04.010

EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer

2023

Journal Article

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography

Vis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography

2023

Journal Article

The effectiveness of a criteria-led discharge initiative on the length of stay of patients who underwent a robotic-assisted laparoscopic prostatectomy

Saad, Jeremy, Shanmugasundaram, Ramesh, Canagasingham, Bertram, Ferguson, Richard, Goolam, Ahmed, Khadra, Mohamed, Ko, Raymod, McCombie, Steve P., Reddy, Sumeet, Roberts, Matthew J., Thangasamy, Isaac, Varol, Celi, Zhong, Wenjie and Arianayagam, Mohan (2023). The effectiveness of a criteria-led discharge initiative on the length of stay of patients who underwent a robotic-assisted laparoscopic prostatectomy. Société Internationale d’Urologie Journal, 4 (6), 458-463. doi: 10.48083/plly8153

The effectiveness of a criteria-led discharge initiative on the length of stay of patients who underwent a robotic-assisted laparoscopic prostatectomy

2023

Conference Publication

Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?

Collin, Harry and Roberts, Matthew (2023). Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?

2023

Conference Publication

Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and prevention

Collin, Harry and Roberts, Matthew (2023). Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and prevention. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and prevention

2023

Journal Article

68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study

Gondoputro, William, Doan, Paul, Katelaris, Athos, Scheltema, Matthijs J., Geboers, Bart, Agrawal, Shikha, Liu, Zhixin, Yaxley, John, Savdie, Richard, Rasiah, Kris, Frydenberg, Mark, Roberts, Matthew J., Malouf, David, Wong, David, Shnier, Ron, Delprado, Warick, Emmett, Louise, Stricker, Phillip D. and Thompson, James (2023). 68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study. Translational Andrology and Urology, 12 (10), 1598-1606. doi: 10.21037/tau-22-708

68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study

2023

Journal Article

Prostate volume analysis in image registration for prostate cancer care: a verification study

Bugeja, Jessica M., Mehawed, Georges, Roberts, Matthew J., Rukin, Nicholas, Dowling, Jason and Murray, Rebecca (2023). Prostate volume analysis in image registration for prostate cancer care: a verification study. Physical and Engineering Sciences in Medicine, 46 (4), 1-12. doi: 10.1007/s13246-023-01342-4

Prostate volume analysis in image registration for prostate cancer care: a verification study

2023

Journal Article

High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints

Raghubar, Arti M., Matigian, Nicholas A., Crawford, Joanna, Francis, Leo, Ellis, Robert, Healy, Helen G., Kassianos, Andrew J., Ng, Monica S. Y., Roberts, Matthew J., Wood, Simon and Mallett, Andrew J. (2023). High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints. npj Precision Oncology, 7 (1) 88, 1-9. doi: 10.1038/s41698-023-00441-5

High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints

2023

Journal Article

DIPPER trial protocol: A multi‐centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002)

Roberts, Matthew J., Conduit, Ciara, Davis, Ian D., Effeney, Rachel M., Williams, Scott, Martin, Jarad M., Hofman, Michael S., Hruby, George, Eapen, Renu, Gianacas, Chris, Papa, Nathan, Lourenço, Richard De Abreu, Dhillon, Haryana M, Allen, Ray, Fontela, Antoinette, Kaur, Baldeep, Emmett, Louise and The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). DIPPER trial protocol: A multi‐centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002). BJU International, 133 (S3), 39-47. doi: 10.1111/bju.16158

DIPPER trial protocol: A multi‐centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002)

2023

Journal Article

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management

Pathmanathan, Shivanshan, Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C., Gan, Chun Loo and Roberts, Matthew J. (2023). Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management. European Journal of Nuclear Medicine and Molecular Imaging, 51 (1), 295-303. doi: 10.1007/s00259-023-06380-4

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management

2023

Journal Article

Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework

Patel, Nishal, Mehawed, Georges, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Chung, Eric, Tse, Vincent and Roberts, Matthew J. (2023). Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework. Urology, 178, 1-8. doi: 10.1016/j.urology.2023.05.002

Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework

2023

Conference Publication

Dr Bot - Does AI provide quality information to prostate cancer patients?

Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Dr Bot - Does AI provide quality information to prostate cancer patients?. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley.

Dr Bot - Does AI provide quality information to prostate cancer patients?

2023

Journal Article

Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand

O' Callaghan, Michael E., Roberts, Matthew, Grummet, Jeremy, Mark, Stephen, Gilbourd, Daniel, Frydenberg, Mark, Millar, Jeremy and Papa, Nathan (2023). Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand. Urologic Oncology: Seminars and Original Investigations, 41 (7), 324.e13-324.e20. doi: 10.1016/j.urolonc.2023.05.011

Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand

2023

Conference Publication

Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND Trial

Roberts, Matthew, Roberts, Natasha, Harley, Simon, Cullen, Karla, Pelecanos, Anita, Vela, Ian, Yaxley, John, Kuchel, Anna, Dhiantravan, Nattakorn, Thomas, Paul and Pattison, David (2023). Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND Trial. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley.

Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND Trial

2023

Journal Article

A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsy

Kelly, Brian D., Ptasznik, Gideon, Roberts, Matthew J., Doan, Paul, Stricker, Phillip, Thompson, James, Buteau, James, Chen, Kenneth, Alghazo, Omar, O'Brien, Jonathan S., Hofman, Michael S., Frydenberg, Mark, Lawrentschuk, Nathan, Lundon, Dara, Murphy, Declan G., Emmett, Louise and Moon, Daniel (2023). A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsy. European Urology Open Science, 53, 90-97. doi: 10.1016/j.euros.2023.05.002

A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsy

Funding

Current funding

  • 2024 - 2030
    Prostate Cancer - FDG - Spatial Imaging (Spatial biology meets PET imaging: A non-invasive, Google Map for Prostate cancer)
    PA Research Foundation
    Open grant

Past funding

  • 2022 - 2025
    Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety and Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Path
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2022 - 2023
    Prospective surgeon-led trials in Prostate Cancer for personalised management and healthcare sustainability
    Viertl Clinical Investigator Award
    Open grant
  • 2021 - 2022
    De-Intensification of Post ProstatEctomy Radiotherapy (DIPPER) incorporating clinical and imaging-based risk stratification: Part 1 - Pilot study (additional site)
    ANZUP Below the Belt Research Fund
    Open grant
  • 2021
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study
    Metro North Hospital and Health Service
    Open grant
  • 2021
    Staging of aggressive prostate cancer 'invisible' to PSMA-PET: The FDG-PET for INvisible Disease (FIND) Trial
    Metro North Hospital and Health Service
    Open grant
  • 2018
    Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer
    Metro North Hospital and Health Service
    Open grant
  • 2015
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2016
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2013
    Optimising collection for metabonomic profiling of ejaculate to complement PCR in prostate cancer detection
    Royal Brisbane and Women's Hospital
    Open grant

Supervision

Availability

Dr Matthew Roberts is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices

    Associate Advisor

    Other advisors: Professor Kristofer Thurecht, Dr Nick Rukin

Media

Enquiries

For media enquiries about Dr Matthew Roberts's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au